Evidence map›Paper›PMID 40869520›Full record

ArticleJournal of clinical medicine2025

Successful Treatment of an Advanced Larynx Carcinoma Using Neo-Adjuvant Chemo-Immunotherapy and Cisplatin/Radiotherapy for a Patient with Rendu-Osler Disease.

Bruno Chauffert, Tamim Alsuliman, Hanene Oueslati, Abdenour Ouikene, Farid Belkhir, Sana Nemmaoui, Alexandre Cau, Agnes Galez, Thomas Garnier, Valéry Salle and 1 more

Abstract readCase Reports
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bruno ChauffertDepartment of Oncology-Hematology, Centre Hospitalier de Saint-Quentin, 1 Av. Michel de l'Hospital BP 608, 02321 Saint-Quentin, France.
Tamim AlsulimanDepartment of Oncology-Hematology, Centre Hospitalier de Saint-Quentin, 1 Av. Michel de l'Hospital BP 608, 02321 Saint-Quentin, France.
Hanene OueslatiDepartment of Radiotherapy, Centre Hospitalier de Saint-Quentin, 02321 Saint-Quentin, France.
Abdenour OuikeneDepartment of Oncology-Hematology, Centre Hospitalier de Saint-Quentin, 1 Av. Michel de l'Hospital BP 608, 02321 Saint-Quentin, France.
Farid BelkhirDepartment of Radiotherapy, Centre Hospitalier de Saint-Quentin, 02321 Saint-Quentin, France.
Sana NemmaouiDepartment of Oncology-Hematology, Centre Hospitalier de Saint-Quentin, 1 Av. Michel de l'Hospital BP 608, 02321 Saint-Quentin, France.
Alexandre CauDepartment of Pharmacy, Centre Hospitalier de Saint-Quentin, 02321 Saint-Quentin, France.
Agnes GalezDepartment of Oto-Rhino-Laryngology, Centre Hospitalier de Saint-Quentin, 02321 Saint-Quentin, France.
Thomas GarnierDepartment of Oto-Rhino-Laryngology, Centre Hospitalier de Saint-Quentin, 02321 Saint-Quentin, France.
Valéry SalleDepartment of Internal Medicine, CHU Amiens-Picardie, 1 Place Victor Pauchet, 80054 Amiens, France.
Reda GaridiDepartment of Oncology-Hematology, Centre Hospitalier de Saint-Quentin, 1 Av. Michel de l'Hospital BP 608, 02321 Saint-Quentin, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cetuximabchemo-immunotherapycisplatincisplatin-enhanced radiotherapypaclitaxelpembrolizumabRendu–Osler diseasesquamous cell carcinoma of larynx

Identifiers

PMID40869520
PMCPMC12386577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.